Management of Upper GI Bleeding
The recommended treatment for upper GI bleeding includes initial resuscitation, high-dose intravenous proton pump inhibitors (80mg bolus followed by 8mg/h continuous infusion for 72 hours), and endoscopic therapy for high-risk lesions. 1
Initial Management
- Assess hemodynamic stability immediately
- Rapid infusion of normal saline or lactated Ringer solution to correct hypovolemia 2
- Blood transfusion when hemoglobin is less than 7 g/dL 2
- Risk stratification using clinical prediction guides (e.g., Glasgow-Blatchford bleeding score) 2
Pharmacological Management
Proton Pump Inhibitors (PPIs)
- First-line pharmacological therapy:
- Empirical high-dose PPI therapy should be started while awaiting endoscopy 1
- After successful endoscopic therapy, administer high-dose IV PPI (80mg bolus followed by 8mg/h continuous infusion for 72 hours) 1
- This is a class effect achievable with either IV omeprazole or pantoprazole 1
- Continue oral PPI therapy after the initial IV treatment phase 1
H2-Receptor Antagonists
- Not recommended for management of acute upper GI bleeding due to inconsistent and marginal benefits compared to PPIs 1, 3
- Meta-analyses have found PPIs to be more effective than H2-receptor antagonists in preventing persistent or recurrent bleeding 3
Somatostatin and Octreotide
- Not recommended in routine management of nonvariceal upper GI bleeding 3, 1
- May be useful in specific scenarios:
- Patients bleeding uncontrollably while awaiting endoscopy
- Patients for whom surgery is contraindicated 1
Endoscopic Management
- Endoscopy should be performed within 24 hours of presentation 2
- Earlier endoscopy (after resuscitation) for high-risk patients with hemodynamic instability 4
- Endoscopic hemostasis is reserved for patients with high-risk endoscopic lesions 1
- Combination therapy (injection plus thermal coagulation) is superior to either treatment alone 1
- Hemostatic clips are a promising alternative or addition to traditional methods 1
Post-Endoscopy Care
- Continue high-dose PPI therapy for 72 hours post-endoscopy (when rebleeding risk is highest) 2
- Patients can be fed within 24 hours if considered at low risk for rebleeding 1
- Test for H. pylori infection and provide eradication therapy if positive 1
- Routine second-look endoscopy is not recommended 1
Management of Treatment Failure
- For failed endoscopic hemostasis, attempt transcatheter arterial embolization before proceeding to surgery 2
- For recurrent ulcer bleeding, use repeat endoscopic therapy 4
- For recurrent variceal bleeding, consider transjugular intrahepatic portosystemic shunt (TIPS) 4
Special Considerations
- Antithrombotic therapy: Evidence suggests better outcomes when these drugs are reintroduced early after bleeding control 4
- Testing for H. pylori during acute bleeding may have increased false-negative rates; confirmatory testing outside acute context may be needed 1
Common Pitfalls to Avoid
- Overuse of IV PPIs before endoscopy regardless of endoscopic findings (observed in 86.2% of patients in some studies) 5
- Continuing IV PPI after endoscopy in patients with low-risk lesions 5
- Delaying endoscopy in high-risk patients 4
- Insufficient PPI dosing after endoscopic therapy for high-risk lesions 3